The Governance and Board Team at Cantargia is responsible for overseeing corporate governance practices, aligning the company's strategic direction with its mission to develop innovative antibody-based treatments targeting IL1RAP for various cancers. This team, consisting of experienced members, ensures compliance with regulations, provides strategic guidance, and supports effective decision-making to drive the company's success and enhance stakeholder value.